Why Antitrust Concerns May Not Affect Axon's Growth
A pending FTC case may just be a speed bump for Axon (NASDAQ: AXON) on its path to dominating the body-cam market and transforming public safety.
In this segment of "Industry Focus" on Motley Fool Live, recorded on Dec. 1, Fool contributors Brian Stoffel and Emily Flippen discuss Axon's ability to grow while navigating an antitrust suit.
Source Fool.com
